Emvision Medical Devices Ltd
Research Emvision Medical Devices Ltd (EMV) on Bullrun: market cap AUD 168.25M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerEMV
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 168.25M
- Financial periodFY2025
- Net income-AUD 9.81M
- Free cash flow-AUD 7.89M
Valuation Snapshot
latest market cap is AUD 168.25M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | -AUD 9.81M | -AUD 7.89M | n/a | -0.11 | AUD 10.46M | AUD 3.53M | AUD 9.28M |
| FY2024 | n/a | -AUD 2.73M | -AUD 6.29M | n/a | -0.03 | AUD 18.60M | AUD 2.90M | AUD 18.52M |
| FY2023 | n/a | -AUD 3.87M | AUD 646.86K | n/a | -0.05 | AUD 9.97M | AUD 3.04M | AUD 5.12M |
| FY2022 | n/a | -AUD 6.11M | -AUD 3.97M | n/a | -0.08 | AUD 6.80M | AUD 737.86K | AUD 7.08M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | AUD 168.25M | n/a | n/a | n/a |
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Emvision Medical Devices Ltd's market cap?
Emvision Medical Devices Ltd's market capitalization is AUD 168.25M.
What does Emvision Medical Devices Ltd do?
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.